Compare CCK & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCK | ICLR |
|---|---|---|
| Founded | 1906 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 9.3B |
| IPO Year | 2003 | 2001 |
| Metric | CCK | ICLR |
|---|---|---|
| Price | $95.76 | $137.16 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 13 |
| Target Price | $121.19 | ★ $178.62 |
| AVG Volume (30 Days) | ★ 1.0M | 981.3K |
| Earning Date | 04-27-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.41% | N/A |
| EPS Growth | ★ 79.72 | N/A |
| EPS | ★ 1.56 | N/A |
| Revenue | ★ $11,665,000,000.00 | N/A |
| Revenue This Year | $5.17 | N/A |
| Revenue Next Year | $2.38 | N/A |
| P/E Ratio | $62.51 | ★ $12.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $89.21 | $66.57 |
| 52 Week High | $116.62 | $211.00 |
| Indicator | CCK | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 38.84 | 70.29 |
| Support Level | $93.91 | $99.11 |
| Resistance Level | $102.17 | $193.87 |
| Average True Range (ATR) | 2.19 | 6.72 |
| MACD | 0.02 | 1.66 |
| Stochastic Oscillator | 20.42 | 91.36 |
Crown Holdings Inc is a producer of metal packaging. The company manufactures beverage cans, metal food cans, and closures, as well as aerosol cans. With the purchase of Signode, the company also has a presence in a wide variety of protective transport packaging. Although it's headquartered in the United States, the vast majority of Crown's sales come from its operations in Europe, South America, and Southeast Asia.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.